Neumora Therapeutics, Inc.'s total assets for Q3 2024 were $352.54M, a decrease of -12.84% from the previous quarter. NMRA total liabilities were $31.80M for the fiscal quarter, a 36.98% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.